These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24591170)

  • 1. The FM/AM world is shaping the future of deep brain stimulation.
    Fasano A; Lozano AM
    Mov Disord; 2014 Feb; 29(2):161-3. PubMed ID: 24591170
    [No Abstract]   [Full Text] [Related]  

  • 2. The FM/AM world is shaping the future of deep brain stimulation.
    Montgomery E; He H
    Mov Disord; 2014 Sep; 29(10):1327. PubMed ID: 25130891
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: the FM/AM world is shaping the future of deep brain stimulation.
    Fasano A; Lozano AM
    Mov Disord; 2014 Sep; 29(10):1327-8. PubMed ID: 25042358
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined stimulation of the substantia nigra pars reticulata and the subthalamic nucleus is effective in hypokinetic gait disturbance in Parkinson's disease.
    Weiss D; Breit S; Wächter T; Plewnia C; Gharabaghi A; Krüger R
    J Neurol; 2011 Jun; 258(6):1183-5. PubMed ID: 21287187
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of subthalamic deep brain stimulation on bradykinesia of proximal and distal upper limb muscles in Parkinson's disease.
    Dafotakis M; Fink GR; Allert N; Nowak DA
    J Neurol; 2008 Mar; 255(3):429-37. PubMed ID: 18343967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of motor fluctuations in Parkinson's disease.
    Korczyn AD
    J Neural Transm (Vienna); 2011 Jun; 118(6):905-6. PubMed ID: 21617891
    [No Abstract]   [Full Text] [Related]  

  • 8. Deep brain stimulation and oropharyngeal dysfunction in Parkinson's disease: a case report.
    Termsarasab P; Tse W
    Parkinsonism Relat Disord; 2015 Jan; 21(1):79-80. PubMed ID: 25465743
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuronal firing patterns in the subthalamic nucleus in patients with akinetic-rigid-type Parkinson's disease.
    Guo S; Zhuang P; Zheng Z; Zhang Y; Li J; Li Y
    J Clin Neurosci; 2012 Oct; 19(10):1404-7. PubMed ID: 22898200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable frequency stimulation of subthalamic nucleus in Parkinson's disease: Rationale and hypothesis.
    Jia F; Hu W; Zhang J; Wagle Shukla A; Almeida L; Meng FG; Okun MS; Li L
    Parkinsonism Relat Disord; 2017 Jun; 39():27-30. PubMed ID: 28392298
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-frequency subthalamic nucleus stimulation in Parkinson's disease.
    Sidiropoulos C; Moro E
    Mov Disord; 2014 Oct; 29(12):1569. PubMed ID: 24989692
    [No Abstract]   [Full Text] [Related]  

  • 12. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease.
    Brocker DT; Swan BD; Turner DA; Gross RE; Tatter SB; Koop MM; Bronte-Stewart H; Grill WM
    Exp Neurol; 2013 Jan; 239():60-7. PubMed ID: 23022917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does deep brain stimulation of the subthalamic nucleus prolong survival in Parkinson's Disease?
    Contarino MF; Marinus J; van Hilten JJ
    Mov Disord; 2018 Jul; 33(6):947-949. PubMed ID: 29644757
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to: Low-frequency subthalamic nucleus stimulation in Parkinson's disease: a randomized clinical trial.
    Khoo HM; Kishima H; Oshino S; Yoshimine T
    Mov Disord; 2014 Oct; 29(12):1569-70. PubMed ID: 24985160
    [No Abstract]   [Full Text] [Related]  

  • 16. Deep brain stimulation in early stage Parkinson's disease may reduce the relative risk of symptom worsening.
    Hacker M; Charles D; Finder S
    Parkinsonism Relat Disord; 2016 Jan; 22():112-3. PubMed ID: 26639979
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive deep brain stimulation in Parkinson's disease.
    Beudel M; Brown P
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S123-6. PubMed ID: 26411502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease.
    Sako W; Nishio M; Maruo T; Shimazu H; Matsuzaki K; Tamura T; Mure H; Ushio Y; Nagahiro S; Kaji R; Goto S
    Mov Disord; 2009 May; 24(7):1076-9. PubMed ID: 19353719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency dependent effects of subthalamic nucleus stimulation in Parkinson's disease.
    Fogelson N; Kühn AA; Silberstein P; Limousin PD; Hariz M; Trottenberg T; Kupsch A; Brown P
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):5-9. PubMed ID: 15911112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.